Increased osteoprotegerin serum levels in men with coronary artery disease

被引:285
作者
Schoppet, M
Sattler, AM
Schaefer, JR
Herzum, M
Maisch, B
Hofbauer, LC
机构
[1] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, Dept Med, D-35033 Marburg, Germany
[2] Univ Marburg, Dept Internal Med, D-35033 Marburg, Germany
[3] Univ Marburg, Dept Cardiol, D-35033 Marburg, Germany
关键词
D O I
10.1210/jc.2002-020775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
osteoprotegerin (OPG) regulates osteoclast and immune functions and appears to represent a protective factor for the vascular system. However, the role of OPG in human atherosclerosis has not been evaluated. In this study, we assessed OPG serum levels in 522 age-matched men who, on the basis of coronary angiography, had either absence of coronary artery disease (CAD) or presence of single-vessel disease, double-vessel disease, or severe triple-vessel disease. OPG serum levels were positively correlated with age (r = 0.28; P < 0.001) and were higher in men with diabetes mellitus (P < 0.01). OPG serum levels in men without CAD were 5.4 +/- 2.0 pmol/liter, compared with 6.1 +/- 2.1 pmol/liter in single-vessel disease (P < 0.005), 5.9 +/- 2.4 in double-vessel disease (P < 0.05), and 6.3 +/- 2.3 pmol/liter in triple-vessel disease (P < 0.001). Moreover, OPG serum levels were positively correlated with the severity of CAD as determined by a CAD scoring system (r = 0.17; P < 0.01). In conclusion, our data underline that OPG serum levels are associated with the severity of CAD and are increased in elderly men and patients with diabetes mellitus. We conclude that increased OPG serum levels may reflect advanced cardiovascular disease in men.
引用
收藏
页码:1024 / 1028
页数:5
相关论文
共 29 条
[21]   LIPOPROTEIN PREDICTORS OF THE SEVERITY OF CORONARY-ARTERY DISEASE IN MEN AND WOMEN [J].
REARDON, MF ;
NESTEL, PJ ;
CRAIG, IH ;
HARPER, RW .
CIRCULATION, 1985, 71 (05) :881-888
[22]   Strategies to optimize CAD prevention in modern cardiology - The "Marburg CAD Prevention Project" [J].
Schaefer, JR ;
Simon, B ;
Soufi, M ;
Sattler, A ;
Noll, B ;
Herzum, M ;
Maisch, B .
HERZ, 2000, 25 (02) :113-116
[23]   RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function [J].
Schoppet, M ;
Preissner, KT ;
Hofbauer, LC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :549-553
[24]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319
[25]   Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells [J].
Standal, T ;
Seidel, C ;
Hjertner, O ;
Plesner, T ;
Sanderson, RD ;
Waage, A ;
Borset, M ;
Sundan, A .
BLOOD, 2002, 100 (08) :3002-3007
[26]   Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status [J].
Szulc, P ;
Hofbauer, LC ;
Heufelder, AE ;
Roth, S ;
Delmas, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3162-3165
[27]   Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications - A statement for health professionals from the American Heart Association [J].
Wexler, L ;
Brundage, B ;
Crouse, J ;
Detrano, R ;
Fuster, V ;
Maddahi, J ;
Rumberger, J ;
Stanford, W ;
White, R ;
Taubert, K .
CIRCULATION, 1996, 94 (05) :1175-1192
[28]   Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis [J].
Yano, K ;
Tsuda, E ;
Washida, N ;
Kobayashi, F ;
Goto, M ;
Harada, A ;
Ikeda, K ;
Higashio, K ;
Yamada, Y .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (04) :518-527
[29]   Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function [J].
Yun, TJ ;
Tallquist, MD ;
Aicher, A ;
Rafferty, KL ;
Marshall, AJ ;
Moon, JJ ;
Ewings, MK ;
Mohaupt, M ;
Herring, SW ;
Clark, EA .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1482-1491